Codexis (CDXS) FCF Margin Growth (3y) (2013 - 2026)
Codexis (CDXS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Codexis |
226.01 Mn |
160.87 Mn |
13.18 Mn |
-1,013.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,013.00 |
| Dec 31, 2025 |
7,818.00 |
| Sep 30, 2025 |
-21,221.00 |
| Jun 30, 2025 |
-9,327.00 |
| Mar 31, 2025 |
-16,435.00 |
| Dec 31, 2024 |
-8,557.00 |
| Sep 30, 2024 |
-12,074.00 |
| Jun 30, 2024 |
-11,784.00 |
| Mar 31, 2024 |
206.00 |
| Dec 31, 2023 |
-13,210.00 |
| Sep 30, 2023 |
-20,279.00 |
| Jun 30, 2023 |
-25,122.00 |
| Mar 31, 2023 |
-6,237.00 |
| Dec 31, 2022 |
538.00 |
| Sep 30, 2022 |
9,118.00 |
| Jun 30, 2022 |
3,939.00 |
| Mar 31, 2022 |
-2,685.00 |
| Dec 31, 2021 |
-599.00 |
| Sep 30, 2021 |
1,665.00 |
| Jun 30, 2021 |
2,989.00 |
